Francesco Berlanda-Scorza

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model

R. Albrecht, A. García-Sastre, P. Palese, 2021, Vaccines.

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

R. Albrecht, A. García-Sastre, P. Palese, 2017, npj Vaccines.

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

R. Albrecht, A. García-Sastre, P. Palese, 2019, Front. Immunol..

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

R. Albrecht, A. García-Sastre, P. Palese, 2017, npj Vaccines.

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

Christopher T. Stamper, D. Bernstein, P. Wilson, 2019, The Lancet. Infectious diseases.